United States DC Circuit
PDK LABS. INC. v. DEA, 03-1008
21 U.S.C. section 971(c)(1), which authorizes the Agency to suspend importation of a listed chemical that may be diverted to the clandestine manufacture of a controlled substance, does not plainly cover the diversion of finished drug products such as plaintiff's ephedrine-containing pills, which could conceivably be sold to, or shoplifted by, people who will then use them to produce methamphetamine.
Appellate Information
- Argued 11/07/2003
- Decided 03/26/2004
- Published 03/26/2004
Judges
- Before: RANDOLPH and ROBERTS, Circuit Judges, and WILLIAMS, Senior Circuit Judge.
Court
- United States DC Circuit
Counsel
- For Appellant:
- Saul Pilchen argued the cause for petitioner. With him on the briefs was Joseph L. Barloon.
- For Appellees:
- Mark T. Quinlivan, Senior Trial Counsel, U.S. Department of Justice, argued the cause for respondent. With him on the brief was Roscoe C. Howard, Jr., U.S. Attorney.